Collaborative and Other Agreements - NIAID - Additional Information (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|---|
Oct. 31, 2011 |
Sep. 30, 2016 |
Sep. 30, 2015 |
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | |||||
Recognition of revenue | $ 205,000 | $ 1,429,000 | $ 1,844,000 | $ 5,412,000 | |
National Institute of Allergy and Infectious Diseases "NIAID" [Member] | |||||
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] | |||||
Total contract amount awarded | $ 28,000,000 | ||||
Contractual term | 5 years | ||||
Recognition of revenue | $ 0 | $ 1,200,000 | $ 1,100,000 | $ 4,100,000 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of revenue earned from products sold or services provided under the terms of a contract, including, but not limited to, government contracts and construction contracts, classified as other. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Contractual term of collaborative, licensing and other arrangements, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Maximum revenue from contract. No definition available.
|
X | ||||||||||
- Details
|